Company Overview of Daiichi Sankyo Korea Co., Ltd.
Daiichi Sankyo Korea Co., Ltd. engages in the development and sale of pharmaceutical products. The company offers products for cardiovascular, which include Lixiana, Mevalotin, Olmete, Olmeact Plus, Sevikar, Sevikar HCT, and Sunrythm. It also offers cravat, a fluoroquinolone antibacterial agent. The company was founded in 1990 and is headquartered in Seoul, South Korea. Daiichi Sankyo Korea Co., Ltd. is a subsidiary of Daiichi Sankyo Co., Ltd.
Founded in 1990
82 2 3453 3300
82 2 3452 9750
Key Executives for Daiichi Sankyo Korea Co., Ltd.
Similar Private Companies By Industry
|Chunggei Pharmaceutical Co.,Ltd.||Asia|
|ABL Bio, Inc.||Asia|
|AD Biotech. Co., Ltd.||Asia|
|Ajinomoto Genexine Co., Ltd.||Asia|
|Asan Pharmaceuticals Co., Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Daiichi Sankyo Korea Co., Ltd., please visit www.daiichisankyo.co.kr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.